Skip to main content

The Ni(II) Complex of 2-Hydroxy-Pyridine-N-Oxide 2-Isothionate: Synthesis, Characterization, Biological Studies, and X-ray Crystal Structures Using (1) Cu Kα Data and (2) Synchrotron Data | Chapter 09 | New Advances in Materials Science and Engineering Vol. 2

C12H20N6NiO6S2 or NiL2(SCN)2](NH4)2.2H2O, where L is 2-hydroxy-pyridine-N-oxide, has been prepared and characterized using elemental analyses, IR, UV and visible spectrometry, magnetic moment measurements, thermal analyses and single crystal X-ray analyis. The results indicate that the complex reacts as a bidentate ligand and is bound to the metal ion via the two oxygen atoms of the ligand (HL). The activation energies, ∆E*, entropies ∆S*, enthalpies ∆H* and order of reactions have been derived from differential thermo-gravimetric (DTA) curves. Based on inhibition zone diameter measurements, the complex exhibited significant antibacterial activity against both Staphylococcus aureus and Escherichia coli. It also exhibited significant antifungal activity against Candida albicans, but no activity was found against Aspergillus flavus. The crystal structure of the Ni(II) complex [C12 H20 N6 Ni O6 S2], Mr = 467.17, was determined from Cu Kα X-ray diffraction data, λ = 1.54178 Å, at 100 K using direct methods. The crystals are monoclinic, space group P21/n with Z = 4 and a = 8.9893(2) Å, b = 17.6680(5) Å, c = 12.5665(3) Å, β = 108.609(1)°. In parallel with this study corresponding results were derived for the crystal structure determined independently from synchrotron X-ray diffraction data, λ = 0.61990 Å, at 100 K. The unit cell parameters derived in this experiment are a = 9.000(2) Å, b = 17.700(4) Å, c = 12.590(3) Å, β = 108.61(3)°. Both studies show 4 O and 2 N atoms coordinating Ni in a distorted octahedral arrangement. Each of the Ni 2-hydroxy-pyridinium-N-oxide moieties is highly planar and the S=C=N-Ni ligands are approximately linear. The crystal structure is characterised by a number of strong hydrogen bonds.

Author(s) Details

Mohamed A. Makhyoun
Department of Chemistry, Alexandria University, Alexandria, Egypt.

Rex A. Palmer
Department of Crystallography, Birkbeck College, London, UK.

Amina A. Soayed
Department of Chemistry, Alexandria University, Alexandria, Egypt.

Heba M. Refaat
Department of Chemistry, Alexandria University, Alexandria, Egypt.

Dina E. Basher
Department of Chemistry, Alexandria University, Alexandria, Egypt.

James Raftery
School of Chemistry, University of Manchester, Manchester, UK.

Carina M. C. Lobley
Diamond Light Source Ltd, Diamond House, Harwell Science and Innovation Campus, Didcot Oxfordshire, OX11 0DE, UK.

Anna J. Warren
Diamond Light Source Ltd, Diamond House, Harwell Science and Innovation Campus, Didcot Oxfordshire, OX11 0DE, UK.

Thomas Sorensen
Diamond Light Source Ltd, Diamond House, Harwell Science and Innovation Campus, Didcot Oxfordshire, OX11 0DE, UK.

Mark Ladd
Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.

View Book: http://bp.bookpi.org/index.php/bpi/catalog/book/123

Comments

Popular posts from this blog

A Prospective Study about Safety and Efficacy of Perioperative Lidocaine Infusion | Chapter 09 | New Horizons in Medicine and Medical Research Vol. 8

 Opioids cause clinically significant side effects such as respiratory depression, immunosuppression, muscle rigidity, negative inotropism, nausea, vomiting, hyperalgesia, urine retention, postoperative ileus, and drowsiness. Perioperative opioids are a major contributor to the United States' and other countries' opioid epidemics. Non-opioid analgesics, particularly lidocaine, are becoming more common for perioperative use as a result of this. A total of 185 adult patients were randomly assigned to one of two groups: control group I (105 patients) [fentanyl group] or group ii (80 patients) [opioid-free anaesthesia group]. Lidocaine 1.5 mg/kg bolus followed by 1.5 mg/kg/h infusion intraoperatively, and 1.5-2 mg/kg/h infusion for 2-8 hours postoperatively were given to patients in both groups at anaesthetic induction. Intraoperatively, both groups received analgesic adjuvants such as diclofenac 75 mg, paracetamol 1 gm, and mgso4 30-50 mg/kg. If the mean arterial pressure (map)

A Brief Study of Middleware Technologies: Programming Applications and Management Systems | Chapter 15 | Novel Research Aspects in Mathematical and Computer Science Vol. 1

  Many platforms, services, applications, hardware, and operating systems are connected through the middleware layer. Because the middleware layer abstracts much low-level complexity and makes applications and software systems portable, it allows disparate systems to interface and function together in harmony. Middleware technologies enable software engineers to swiftly construct software systems and applications, allowing developers to focus on more important tasks. This chapter examines several types of middleware systems and discusses middleware capabilities, middleware operation, middleware's function in cloud-based systems, and the best middleware platforms to use. Middleware systems are widely utilised and can be found in practically any software system or application. Middleware programmes provide as a link between many sorts of systems and protocols. They serve as a mechanism for various systems. To successfully exchange information, it runs on a variety of operating system

Patients’ Perspective of Acute Post-operative Pain Management: A Multicentre Survey of Tertiary Hospitals in Maharashtra, India | Chapter 08 | New Horizons in Medicine and Medical Research Vol. 8

 When postoperative pain is adequately controlled, patients' satisfaction and patient-related outcomes (PROs) increase. Understanding the patients' perspective is crucial since it supports in the formulation of improvement strategies. Because wrong attitudes and assumptions might block pain alleviation, patients' attitudes and beliefs are critical. As a result, a multicenter study of patients' attitudes, beliefs, experiences, and satisfaction levels with acute postoperative pain management was done in Maharashtra's tertiary hospitals. In addition, the responses were examined to evaluate if the Acute Pain Service (APS) resulted in improved patient outcomes and satisfaction. A 13-item questionnaire adapted from previous studies was used to capture patients' experiences with postoperative pain treatment. The responses of 179 patients are included in the study. The findings revealed that 91.6 percent of patients experienced postoperative pain, with 75.5 percent